This inventor holds 1 USPTO granted patent. Top assignee: Quark Pharmaceuticals, Inc.. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Sylvie Luria: Innovator in Hypoxia-Regulated Genes
Introduction
Sylvie Luria is a prominent inventor based in Nes Ziona, Israel. She has made significant contributions to the field of biotechnology, particularly in the area of hypoxia-regulated genes. Her innovative work has the potential to impact medical treatments and diagnostics.
Latest Patents
Sylvie Luria holds one patent related to hypoxia-regulated genes. This patent involves purified, isolated, and cloned nucleic acid polynucleotides encoding hypoxia-regulating genes and their associated proteins. The invention also includes antibodies directed against these proteins, which are detailed in sequences set forth in SEQ ID No:1 through SEQ ID No:6. Furthermore, the patent provides methods for regulating angiogenesis or apoptosis and diagnosing ischemia in patients by analyzing bodily fluids or tissue samples for specific gene products.
Career Highlights
Sylvie Luria is currently employed at Quark Pharmaceuticals, Inc., where she continues to advance her research in biotechnology. Her work focuses on developing innovative solutions for medical challenges related to hypoxic conditions.
Collaborations
Some of her notable coworkers include Paz Einat and Rami Skaliter, who contribute to the collaborative environment at Quark Pharmaceuticals, Inc.
Conclusion
Sylvie Luria's contributions to the field of hypoxia-regulated genes exemplify the impact of innovative research in biotechnology. Her work not only enhances our understanding of gene regulation but also paves the way for new therapeutic approaches.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile